Minnesota has one of the country’s most restrictive medical marijuana programs, and MMJ businesses in the state have experienced significant financial, management and legal issues. However, it isn’t necessarily all gloom and doom when it comes to the future of Minnesota’s MMJ businesses. Nic Easley, a national cannabis consultant and CEO of Denver-based 3C Consulting, […]Read More
The chief executive of one of Minnesota’s two medical marijuana manufacturers has left the company after years of financial losses.
Andrew Bachman, LeafLine Labs’ co-founder and its chief executive since 2016, is no longer with the company “in any official capacity,” the company said Thursday in a statement to the Associated Press.Read More
Minnesota has been among the most restrictive medical marijuana markets in the United States for years, with only two licensed producers serving all registered MMJ patients, a ban on edibles and cannabis flower and a narrow qualifying conditions list. Those factors add up to a small patient pool and questions about whether Minnesota’s two vertically […]Read More
Rising acceptance for hemp and CBD – combined with easing regulations at the state level – caused U.S. hemp production to surge in 2017. From 2016 to 2017, the number of acres licensed for hemp cultivation in the top 10 hemp-growing states grew by 140% – while the number of hemp producers doubled over the same […]Read More
Ever wondered why the U.S. hemp harvest is so tiny despite the crop’s adaptability and market potential?
Minnesota is a great place to find some answers.
The North Star State has allowed modern hemp production since 2016 and has flexible rules on how the crop can be used.Read More
A San Diego-based real estate company that caters to medical cannabis cultivators has filed paperwork with the Securities and Exchange Commission disclosing plans to raise $100 million. If successful, Innovative Industrial Properties’ raise would be one of the larger funding efforts for a U.S. cannabis business. The company – which began listing as IIPR on the New […]Read More
A medical marijuana company that failed to win a Pennsylvania cultivation license has dropped a lawsuit against the state’s health department demanding the agency revoke a license awarded to another grower. Scranton-based BrightStar Biomedics charged in a lawsuit filed last month that Pennsylvania Medical Solutions didn’t disclose on its application that it was under criminal […]Read More
A decision by Target Corp. to start selling CBD supplements last week had the hemp industry cheering – until the Minneapolis-based retail giant yanked the products. Target’s decision to stop selling CW Hemp supplements and oils followed a news release from the manufacturer, CW Hemp, saying the whole CBD industry “has officially gone mainstream.” Within […]Read More
An unusual attempt by Iowa to work with another state to transport medical marijuana oil across state lines is on hold amid legal concerns it could invite scrutiny from the federal government. Iowa’s MMJ law, updated this year, mandates that the state license two cannabis oil producers and five dispensaries in the state by the end of […]Read More
By John Schroyer
Only 26 states in the United States – along with Washington DC – allow independent campaigns to place ballot measures before the general public. Which means the only way to change state laws in almost half the country is through the legislature.
For cannabis advocates, that means pinning legalization hopes on lawmakers, not voters.Read More
At least one Native American tribe – on the White Earth reservation in northwestern Minnesota – has decided to take a leap and get into the hemp business. The tribe has spent $100,000 on just a few acres of the crop, according to Minnesota Public Radio, but is hoping the return on its investment will […]Read More
Minnesotans who suffer from post-traumatic stress disorder are now permitted to start buying medical marijuana from the state’s dispensaries, potentially providing a boost to the state’s sluggish MMJ program. Minnesota approved PTSD as a new qualifying condition late in 2016, but patients weren’t permitted to obtain medical cannabis to treat the illness until Aug. 1. […]Read More
- June 22, 2018June 22, 2018
- June 21, 2018
Read the Issue